Genetics of attention-deficit/hyperactivity disorder: an update

被引:62
|
作者
Akutagava-Martins, Glaucia Chiyoko [1 ]
Rohde, Luis Augusto [2 ,3 ]
Hutz, Mara Helena [1 ]
机构
[1] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil
[2] Hosp Clin Porto Alegre, Child & Adolescent Psychiat Div, Porto Alegre, RS, Brazil
[3] Inst Dev Psychiat Children & Adolescents INCT CNP, Porto Alegre, RS, Brazil
关键词
susceptibility; CNVs; ADHD; genetics; pathway analysis; polygenic risk score analysis; GWAS; DEFICIT HYPERACTIVITY DISORDER; GENOME-WIDE-ASSOCIATION; COPY NUMBER VARIANTS; RARE VARIANTS; DE-NOVO; HYPERACTIVE/IMPULSIVE SYMPTOMS; MOLECULAR-GENETICS; GENERAL-POPULATION; BIPOLAR DISORDER; POLYGENIC RISK;
D O I
10.1586/14737175.2016.1130626
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder affecting children, adolescents, and adults. The prevalence is estimated at 5 to 7% of school-aged children and 2.5 to 5% of adults. The phenotype is complex and heterogeneous, presenting variable clinical features, developmental course, and outcome. The genetic susceptibility to ADHD is attributed to both common and rare variants from a broad range of genes related mainly to neurotransmission and neurodevelopment pathways. However, it has been difficult to identify the genetic risk variants that account for the high heritability of this disorder. In this paper, we present recent findings from molecular genetics studies on both child and adult ADHD. Challenges and future directions for ADHD genetic studies are reviewed and discussed.
引用
收藏
页码:145 / 156
页数:12
相关论文
共 50 条
  • [21] Catecholamine dysfunction in attention-deficit/hyperactivity disorder - An update
    Prince, Jefferson
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (03) : S39 - S45
  • [22] Psychosocial Interventions in Attention-Deficit/Hyperactivity Disorder: Update
    Antshel, Kevin M.
    CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2015, 24 (01) : 79 - +
  • [23] Update on atomoxetine in the treatment of attention-deficit/hyperactivity disorder
    Vaughan, Brigette
    Fegert, Joerg
    Kratochvil, Christopher J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (04) : 669 - 676
  • [24] Attention-Deficit/Hyperactivity Disorder Genomics: Update for Clinicians
    Josephine Elia
    Jillan Sackett
    Terri Turner
    Martin Schardt
    Shih-Ching Tang
    Nicole Kurtz
    Maura Dunfey
    Nadia A. McFarlane
    Aita Susi
    David Danish
    Alice Li
    Jenelle Nissley-Tsiopinis
    Karin Borgmann-Winter
    Current Psychiatry Reports, 2012, 14 : 579 - 589
  • [26] Management of Attention-Deficit Disorder and Attention-Deficit/Hyperactivity Disorder Drug Intoxication in Dogs and Cats: An Update
    Stern, Laura
    Schell, Mary
    VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 2018, 48 (06) : 959 - +
  • [27] Attention: Attention-deficit/hyperactivity disorder
    Shulman, Stanford T.
    PEDIATRIC ANNALS, 2008, 37 (01): : 5 - 6
  • [28] The Genetics of Attention-Deficit/Hyperactivity Disorder: Failure or Learning Process?
    Cortese, Samuele
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (10): : 839 - 840
  • [29] Not in their genes: A critical view of the genetics of attention-deficit hyperactivity disorder
    Joseph, J
    DEVELOPMENTAL REVIEW, 2000, 20 (04) : 539 - 567
  • [30] Attention-deficit hyperactivity disorder
    Posner, Jonathan
    Polanczyk, Guilherme V.
    Sonuga-Barke, Edmund
    LANCET, 2020, 395 (10222): : 450 - 462